Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Am Heart J. 2018 Mar 24;200:118–124. doi: 10.1016/j.ahj.2018.03.011

Table 3.

Proportion of Clinicians Very Likely/Likely to Prescribe Statin Therapy in the Primary Prevention Hypothetical Scenarios

Scenario All (N=774) Adopted ACC/AHA Guidelines
Yes (N=574) No (N=200) p-value
Prescribe Statin Therapy
Diabetes 654 (84.5%) 483 (84.2%) 171 (85.5%) 0.68
High risk/high LDL-C 719 (92.9%) 537 (93.6%) 182 (91.0%) 0.23
Low risk/high LDL-C 311 (40.2%) 234 (40.8%) 77 (38.5%) 0.57
Add a Non-Statin Lipid Lowering Treatment
High LDL-C despite adherence to high-intensity statin 398 (51.4%) 287 (50.0%) 111 (55.5%) 0.18

All abbreviations can be found in Tables 1 and 2.